Spectrum of cardiovascular disease in HIV-infected patients;Espectro de enfermedad cardiovascular en pacientes infectados por el VIH

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 27, Issue SUPPL. 1, 2009, Pages 3-9

  Lozano, Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Arteriosclerosis; Cardiovascular risk; HIV infection; Ischemic heart disease

Indexed keywords

ACUTE HEART INFARCTION; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTERY DISEASE; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CORONARY ARTERY; CORONARY ARTERY CALCIFICATION; ENDOTHELIAL DYSFUNCTION; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; SILENT MYOCARDIAL INFARCTION; STROKE; VASODILATATION;

ADULT; ANTI-HIV AGENTS; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIAGNOSTIC IMAGING; DISEASE SUSCEPTIBILITY; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 76749105570     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(09)73439-1     Document Type: Article

References (66)

1. Savés M., Chêne G., Ducimetière P., Leport C., Le Moal G., Amouyel P., et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 37 (2003) 292-298
2. Currier J.S., Lundgren J.D., Carr A., Klein D., Sabin C.A., Sax P.E., et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 118 (2008) e29-e35
3. Martínez E., Larrouse M., and Gatell J.M. Cardiovascular disease and HIV infection: host, virus, or drugs?. Curr Opin Infect Dis 22 (2009) 28-34
4. Klein D., Hurley L.B., Quesenberry Jr. C.P., and Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?. J Acquir Immune Defic Syndr 30 (2002) 471-477
5. Currier J.S., Taylor A., Boyd F., Dezii C.M., Kawabata H., Burtcel B., et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 33 (2003) 506-512
6. Triant V.A., Lee H., Hadigan C., and Grinspoon S.K. Increased acute myocardial infarction and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metabol 92 (2007) 2506-2512
7. Obel N., Thompson H.F., Kronborg G., Larsen C.S., Hildebrandt P.R., Sorensen H.T., et al. Ischemic heart disease in HIV-infected and uninfected individuals: a populationbased cohort study. Clin Infect Dis 44 (2007) 1625-1631
8. Friis-Möller N., Sabin C.A., Weber R., d'Arminio-Monforte A., El-Sadr W.M., Reiss P., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
9. Friis-Möller N., Reiss P., Sabin C.A., Weber R., d'Arminio-Monforte A., El-Sadr W.M., et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356 (2007) 1723-1735
10. D:A:D Study Group. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration. Lancet 356 (2008) 1723-1735
11. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2003) 702-710
12. Iloeje U.H., Yuan Y., L'Italien G., Mauskopf J., Holmberg S.D., Moorman A.C., et al. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med 6 (2005) 37-44
13. Carr A., Grund B., Neuhaus J., El-Sadr W.M., Grandits G., Gibert C., et al. Asymptomatic myocardial ischaemia in HIV-infected adults. AIDS 22 (2008) 257-267
14. Duong M., Cottin Y., Piroth L., Fargeot A., Lhuiller I., Bobillier M., et al. Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Clin Infect Dis 34 (2002) 523-528
15. Nayak G., Ferguson M., Tribble D.R., Porter C.K., Rapena R., Marchicelli M., et al. Cardiac diastolic dysfunction is prevalent in HIV-infected patients. AIDS Patient Care STDS 23 (2009) 231-238
16. Schuster I., Thöni G.J., Edérhy S., Walther G., Nottin S., Vinet A., et al. Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy. Am J Cardiol 101 (2008) 1213-1217
17. Cole J.W., Pinto A.N., Hebel J.R., Buchholz D.W., Earley C.J., Johnson C.J., et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 35 (2004) 51-56
18. Corral I., Quereda C., Moreno A., Pérez-Elías M.J., Dronda F., Casado J.L., et al. Cerebrovascular ischemic events in HIV-1-Infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 27 (2009) 559-563
19. Hsue PY, Hunt PW, Scnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated therosclerosis. AIDS. 2009. Epub ahead of print.
20. Lorenz M.W., Stephan C., Harmjanz A., Staszewski S., Buehler A., Bickel M., et al. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis 196 (2008) 720-726
21. Lekakis J., Tsiodras S., Ikonomidis I., Palios J., Poulakou G., Rallidis L., et al. HIV-positive patients treated with PI have vascular changes resembling those observed in atherosclerotic cardiovascular disease. Clin Science (Lond) 115 (2008) 189-196
22. Kaplan R.C., Kingsley L.A., Gange S.J., Benning L., Jacobson L.P., Lazar J., et al. Low CD4+ T cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 22 (2008) 1615-1624
23. Grunfeld C, Delaney J, Wanke C, Currier J, Scherzer R, Biggs M, et al. HIV infection is an independent risk factor for atherosclerosis similar in magnitude to traditional cardiovascular disease risk factors. Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal: February 8-11, 2009. Abstract 746.
24. Jericó C., Knobel H., Calvo N., Sorli M.L., Guelar A., Gimeno-Bayón J.L., et al. Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy. Stroke 37 (2006) 812-817
25. Maggi P., Serio G., Epifani G., Fiorentino G., Saracino A., Fico C., et al. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 14 (2000) F123-F128
26. Depairon M., Chessex S., Sudre P., Redondi N., Doser N., Chave J.P., et al. Premature atherosclerosis in HIV-infected individuals: focus on protease inhibitor therapy. AIDS 15 (2001) 329-334
27. Seminari E., Pan A., Voltini G., Carnevale G., Maserati R., Minoli L., et al. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis 162 (2002) 433-438
28. Chironi G., Escaut L., Gariepy J., Cagny A., Teicher E., Monsuez J.J., et al. Carotid intimamedia thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 32 (2003) 490-493
29. Van Vonderen M.GA., Smulders Y.M., Stehouwer C.DA., Danner S.A., Gundy C.M., et al. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy. J Acquir Immune Defic Syndr 50 (2009) 153-161
30. McComsey G.A., O'Riordan M., Hazen S.L., El-Bejjani D., Bhatt S., Brennan M.L., et al. Increased carotid intima-media thickness in HIV infected children. AIDS 21 (2007) 921-927
31. Giuliano I.C.B., De Freitas S.F.T., De Souza M., and Caramelli B. Subclinic atherosclerosis and cardiovascular risk factors in HIV-infected children: PERI study. Coron Artery Dis 19 (2008) 167-172
32. Hsue P.Y., Lo J.C., Franklin A., Bolger A.F., Martin J.N., Deeks S.G., et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109 (2004) 1603-1608
33. Mercié P., Thiebaut R., Aurillac-Lavignolle V., Pellegrin J.L., Ivorra-Vives M.C., Cipriano C., et al. Carotid intima-media thickness is slightly increased over time in HIV-1- infected patients. HIV Med 6 (2005) 380-387
34. Currier J.S., Kendall M.A., Zackin R., Henry W.K., Alston-Smith B., Torriani F.J., et al. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitors exposure. AIDS 19 (2005) 927-933
35. Currier J.S., Kendall M.A., Henry W.K., Alston-Smith B., Torriani F.J., Tebas P., et al. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS 21 (2007) 1137-1145
36. Kingsley L.A., Cuervo-Rojas J., Muñoz J., Palella F.J., Post W., Witt M.D., et al. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS 22 (2008) 1589-1599
37. Acevedo M., Sprecher D.L., Calabrese L., Pearce G.L., Coyner D.L., Halliburton S.S., et al. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: a call for cardiovascular prevention. Atherosclerosis 163 (2002) 349-354
38. Talwani R., Falusi O.M., Mendes de León C.F., Nerad J.L., Rich S., Proia L.A., et al. Electron beam computed tomography for assessment of coronary artery disease in HIVinfected men receiving antiretroviral therapy. J Acquir Immune Defic Syndr 30 (2002) 191-195
39. Mangili A., Gerrior J., Tang A.M., O'Leary D.H., Polak J.K., Schaefer E.J., et al. Risk of cardiovascular disease in a cohort of hIV-infected adults: a study using carotid intima- media thickness and coronary artery calcium score. Clin Infect Dis 43 (2006) 1482-1489
40. Meng Q., Lima J.A., Lai H., Vlahov D., Celentano D.D., Strathdee S.A., et al. Coronary artery calcification, atherogenic lipid changes, and increased erythrocyte volume in black injection drug users infected with human immunodeficiency virus-1-treated with protease inhibitors. Am Heart J 144 (2002) 642-648
41. Adeyemi O.M., Rezai K., Akimov S., Hwang J., Sha B.E., and Kessler H.A. Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patients. J Acquir Immune Defic Syndr 49 (2008) 113-114
42. Lebech A.M., Kristoffersen U.S., Wiinberg N., Kofoed K., Andersen O., Hesse B., et al. Coronary and peripheral endotelial function in HIV patients studied with positrom emission tomography and flow-mediated dilatation: relation to hypercholesterolemia. Eur J Nucl Med Mol Imaging 35 (2008) 2049-2058
43. Périard D., Cavassini M., Taffé P., Chevalley M., Senn L., Chapuis-Taillard C., et al. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis 46 (2008) 761-767
44. Palacios R., Alonso I., Hidalgo A., Aguilar I., Sánchez M.A., Valdivielso P., et al. Peripheral arterial disease in HIV patients older than 50 years of age. AIDS Res Human Retroviruses 8 (2008) 1043-1046
45. Gutiérrez F., Bernal E., Padilla S., Hernández I., and Masiá M. Relationship between anklebrachial index and carotid intima-media thickness in HIV-infected patients. AIDS 22 (2008) 1369-1371
46. Sharma A., Holman S., Pitt R., Minkoff H.L., Dehovitz J.A., and Lazar J. Peripheral arterial disease in HIV-infected and uninfected women. HIV Med 8 (2007) 555-560
47. Stein J.H., Klein M.A., Bellehumeur J.L., McBride P.E., Wiebe D.A., Otvos J.D., et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104 (2001) 257-262
48. Nolan D., Watts G.F., Herrmann S.E., French M.A., John M., and Mallal S. Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?. QJM 96 (2003) 825-832
49. Blum A., Hadas V., Burke M., Yust I., and Kessler A. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol 28 (2005) 149-153
50. Solages A., Vita J.A., Thornton D.J., Murray J., Heeren T., Craven D.E., et al. Endothelial function in HIV-infected persons. Clin Infect Dis 42 (2006) 1325-1332
51. Van Wijk J.P., De Koning E.J., Cabezas M.C., Joven J., Op't Roodt J., Rabelink T.J., et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 47 (2006) 1117-1123
52. Blanco J.J., García I.S., Cerezo J.G., De Rivera J.M., Anaya P.M., Raya P.G., et al. Endothelial function in HIV-infected patients with low or mild cardiovascular risk. J Antimicrob Chemother 58 (2006) 133-139
53. Andrade A.C., Ladeia A.M., Netto E.M., Mascarenhas A., Cotter B., Benson C.A., et al. Cross-sectional study of endothelial function in HIV-infected patients in Brazil. AIDS Res Hum Retroviruses 24 (2008) 27-33
54. Charakida M., Donald A.E., Green H., Storry C., Clapson M., Caslake M., et al. Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy. Circulation 112 (2005) 103-109
55. Beckman J.A., Goldfine A.B., Dunaif A., Gerhard-Herman M., and Creager M.A. Endothelial function varies according to insulin resistance disease type. Diabetes Care 30 (2007) 1226-1232
56. Mondy K.E., De las Fuentes L., Waggoner A., Onen N.F., Bopp C.S., Lassa-Claxton S., et al. Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIVinfected persons on long-term highly active antiretroviral therapy. AIDS 22 (2008) 849-856
57. Hürlimann D., Chenevard R., Ruschitzka F., Flepp M., Enseleit F., Béchir M., et al. Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial. Heart 92 (2006) 110-112
58. Baker J, Duprez D, Rapkin J, Grimm R, Neaton J, Henry K. Untreated HIV infection is associated with impaired arterial elasticity. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections. Montreal: February 8-11, 2009. Abstract 725.
59. Sevastianova K., Sutinen J., Westerbacka J., Ristola M., and Yki-Järvinen H. Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy. Antivir Ther 10 (2005) 925-935
60. Jericó C., Knobel H., Montero M., Sorli M.L., Guelar A., Gimeno J.L., et al. Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 18 (2005) 1396-1401
61. Baekken M., Os I., Sanvik L., and Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. J Hypertens 26 (2008) 2126-2133
62. Coloma Conde A.G., Álvarez Albarrán M., Roca-Cusach Coll A., Domingo Pedrol P., and Puig Campmany M. Prevalence of arterial hypertension and lipid profile in HIV patients. Med Clin (Barc) 131 (2008) 681-684
63. Palacios R., Santos J., García A., Castells E., González M., Ruiz J., et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients. HIV Med 7 (2006) 10-15
64. Thiebaut R., El Sadr W.M., Friis-Moller N., Rickenbach M., Reiss P., Monforte A.D., et al. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther 10 (2005) 811-823
65. Seaberg E., Muñoz A., Lu M., Detels R., Margolick J., Riddler A., et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19 (2005) 953-960
66. Grandominico J.M., and Fichtenbaum C.J. Short-term effect of HAART on blood pressure in HIV-infected individuals. HIV Clin Trials 9 (2008) 52-60